Navigation Links
CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million
Date:8/30/2011

ne to mild or none 2 hours after dosing (p<0.0001) in 391 patients. Differentiation of individual doses from placebo was seen as early as 30 minutes after dosing. Lasmiditan also achieved secondary endpoints, including relief of nausea, photophobia and phonophobia.  Importantly, because there was no evidence of drug-related cardiovascular effects or chest symptoms in the previous five clinical studies, CoLucid expects the pivotal Phase 3 studies to confirm that lasmiditan's side effect profile is highly differentiated from triptans and ergotamines.

About CoLucid Pharmaceuticals, Inc.

CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's investors include Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds and Triathlon Medical Ventures. The company's pipeline includes lasmiditan, a novel treatment for migraine headache, COL-204 for wake promotion, and a conjugated stigmine platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. For more information, please visit CoLucid at www.colucid.com.

Media Contact: Kathy Kelly, CoLucid Pharmaceuticals, Inc., 919-806-4304, kkelly@colucid.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CoLucid Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CoLucid Appoints Thomas P. Mathers as Chief Executive Officer
2. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Now available for sale, The Armor1 Ankle Roll ... ankle sprains by cushioning the ankle from an inversion ... the outside of any shoe type and allows the ... offering protection against sprains. With customers in physical therapy, ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
(Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... , , ... U.S. Food and Drug Administration today warned consumers and health care professionals about a ... or long-term use of a class of medications called proton pump inhibitors. The product ... , , ...
... ALLENTOWN, Pa. and CAMPBELL, Calif. ... physicians and patients sophisticated risk characterization and personalized ... performing a battery of advanced tests, offering an ... MD, Hunter,s Medical Director stated:  "With appropriate risk ...
Cached Medicine Technology:FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors 2FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors 3Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... 22, 2015 Joan Lunden, award-winning American ... at the upcoming 32nd Annual Miami Breast Cancer ... Education Resource®, LLC (PER®) , shares that “a fast-growing, ... undetected if she had not followed up her clean ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... Healthcare Realty Trust Incorporated (NYSE: HR ) ... 2009. Funds from operations ("FFO") per diluted common share ... compared with $0.39 for the three months ended March 31, ... share for the three months ended March 31, 2009, before ...
... (NYSE: AOC ) Chairman, Lester B. Knight will host ... 10:00 a.m. Central Time. A webcast of the presentation and ... available via the Internet. This listen-only webcast can be accessed ... www.aon.com . The webcast will be archived ...
... going forward, experts say , , MONDAY, May 11 (HealthDay News) ... and is likely to be comparable to other 20th century ... expert analysis concludes. , The analysis also suggests that the ... in Mexico, the outbreak,s epicenter, may have already reached 32,000 ...
... Health Week, National Osteoporosis Awareness and Prevention Month and National Arthritis ... with others nationwide , ... Minneapolis, Minnesota (PRWEB) May ... women. In addition to celebrating Mother,s Day, women across the country ...
... 16% to 20% in fiscal 2009SCOTTSDALE, Ariz., May 11 ... an over-the-counter healthcare company that develops and markets Zicam(R) ... better(R)," today announced financial results for its fourth quarter ... the fiscal year ended March 31, 2009, net sales ...
... Study suggests MRI scans better than questionnaires for evaluations ... seniors who,ve had a stroke fail to report that ... scans rather than patient self-reporting to determine stroke history. ... years and older (average age 80.1) in Manhattan. They ...
Cached Medicine News:Health News:Healthcare Realty Trust Announces First Quarter Results 2Health News:Healthcare Realty Trust Announces First Quarter Results 3Health News:Healthcare Realty Trust Announces First Quarter Results 4Health News:Healthcare Realty Trust Announces First Quarter Results 5Health News:Healthcare Realty Trust Announces First Quarter Results 6Health News:Healthcare Realty Trust Announces First Quarter Results 7Health News:Healthcare Realty Trust Announces First Quarter Results 8Health News:Healthcare Realty Trust Announces First Quarter Results 9Health News:Aon to Webcast Annual Shareholders' Meeting 2Health News:Study Supports Swine Flu's Pandemic Potential 2Health News:Study Supports Swine Flu's Pandemic Potential 3Health News:Study Supports Swine Flu's Pandemic Potential 4Health News:The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories 2Health News:The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories 3Health News:The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories 4Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 2Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 3Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 4Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 5Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 6Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 7Health News:Seniors Often Misstate Stroke History 2
... Zeiss was to find innovative solutions ... for preoperative computation of intraocular lenses ... work is the IOLMaster - a ... and setting a new standard for ...
Ahmed Glaucoma Valve with Pars Plana Clip....
... Long-term biocompatibility is established. Provides a robust ... ensure correct positioning on the globe. Pressure ... which, when covered by Tenons tissue, acts ... postoperative hypotony. The range of implants allows ...
... a low implant profile, 0.84mm, for better ... insertion is technically simpler and allows a ... installed with less trauma than multiple quadrant ... implant were designed to minimize bleb height ...
Medicine Products: